Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Joyner and Arturo Casadevall.
Michael Joyner
Connection Strength
6.135
Arturo Casadevall
  1. The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19. mBio. 2021 03 02; 12(2).
    View in: PubMed
    Score: 0.932
  2. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021 03 18; 384(11):1015-1027.
    View in: PubMed
    Score: 0.924
  3. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020 09 01; 130(9):4791-4797.
    View in: PubMed
    Score: 0.901
  4. Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 08 11; 12(1):4864.
    View in: PubMed
    Score: 0.240
  5. COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8).
    View in: PubMed
    Score: 0.240
  6. Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy. Clin Infect Dis. 2021 08 02; 73(3):e540-e542.
    View in: PubMed
    Score: 0.240
  7. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne). 2021; 8:684151.
    View in: PubMed
    Score: 0.237
  8. Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality. Elife. 2021 06 04; 10.
    View in: PubMed
    Score: 0.237
  9. Use of convalescent plasma in COVID-19 patients with immunosuppression. Transfusion. 2021 08; 61(8):2503-2511.
    View in: PubMed
    Score: 0.237
  10. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities. J Clin Invest. 2021 04 01; 131(7).
    View in: PubMed
    Score: 0.234
  11. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1262-1275.
    View in: PubMed
    Score: 0.232
  12. Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19. Clin Microbiol Newsl. 2021 Feb 15; 43(4):23-32.
    View in: PubMed
    Score: 0.232
  13. Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. N Engl J Med. 2021 01 14; 384(2):189.
    View in: PubMed
    Score: 0.230
  14. The Assessment of Convalescent Plasma Efficacy against COVID-19. Med (N Y). 2020 Dec 18; 1(1):66-77.
    View in: PubMed
    Score: 0.230
  15. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. J Clin Invest. 2020 10 01; 130(10):5112-5114.
    View in: PubMed
    Score: 0.226
  16. A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. JAMA. 2020 08 04; 324(5):455-457.
    View in: PubMed
    Score: 0.224
  17. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc. 2020 09; 95(9):1888-1897.
    View in: PubMed
    Score: 0.223
  18. COVID-19 convalescent plasma: Interim recommendations from the AABB. Transfusion. 2021 04; 61(4):1313-1323.
    View in: PubMed
    Score: 0.058
  19. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.